Weverling GJ - Search Results

1

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

Weverling GJ, Mocroft A, Ledergerber B, Kirk O, Gonzáles-Lahoz J, d'Arminio Monforte A, Proenca R, Phillips AN, Lundgren JD, Reiss P. Weverling GJ, et al. Lancet. 1999 Apr 17;353(9161):1293-8. doi: 10.1016/s0140-6736(99)03287-0. Lancet. 1999. PMID: 10218526

2

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.

Reijers MH, Weverling GJ, Jurriaans S, Wit FW, Weigel HM, Ten Kate RW, Mulder JW, Frissen PH, van Leeuwen R, Reiss P, Schuitemaker H, de Wolf F, Lange JM. Reijers MH, et al. Among authors: weverling gj. Lancet. 1998 Jul 18;352(9123):185-90. doi: 10.1016/s0140-6736(98)06193-5. Lancet. 1998. PMID: 9683207 Clinical Trial.

3

Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort.

Dieleman JP, Jambroes M, Gyssens IC, Sturkenboom MC, Stricker BH, Mulder WM, de Wolf F, Weverling GJ, Lange JM, Reiss P, Brinkman K; ATHENA Study Group. Dieleman JP, et al. Among authors: weverling gj. AIDS. 2002 Mar 29;16(5):737-45. doi: 10.1097/00002030-200203290-00009. AIDS. 2002. PMID: 11964530

4

Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy.

Foudraine NA, Weverling GJ, van Gool T, Roos MT, de Wolf F, Koopmans PP, van den Broek PJ, Meenhorst PL, van Leeuwen R, Lange JM, Reiss P. Foudraine NA, et al. Among authors: weverling gj. AIDS. 1998 Jan 1;12(1):35-41. doi: 10.1097/00002030-199801000-00005. AIDS. 1998. PMID: 9456253 Clinical Trial.

5

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

Wit FW, van Leeuwen R, Weverling GJ, Jurriaans S, Nauta K, Steingrover R, Schuijtemaker J, Eyssen X, Fortuin D, Weeda M, de Wolf F, Reiss P, Danner SA, Lange JM. Wit FW, et al. Among authors: weverling gj. J Infect Dis. 1999 Apr;179(4):790-8. doi: 10.1086/314675. J Infect Dis. 1999. PMID: 10068573

6

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.

Reijers MH, Weigel HM, Hart AA, Ten Kate RW, Mulder JW, Reiss P, Schuitemaker H, Hoetelmans RM, Weverling GJ, Lange JM. Reijers MH, et al. Among authors: weverling gj. AIDS. 2000 Jan 7;14(1):59-67. doi: 10.1097/00002030-200001070-00007. AIDS. 2000. PMID: 10714568 Clinical Trial.

7

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.

den Brinker M, Wit FW, Wertheim-van Dillen PM, Jurriaans S, Weel J, van Leeuwen R, Pakker NG, Reiss P, Danner SA, Weverling GJ, Lange JM. den Brinker M, et al. Among authors: weverling gj. AIDS. 2000 Dec 22;14(18):2895-902. doi: 10.1097/00002030-200012220-00011. AIDS. 2000. PMID: 11153671 Clinical Trial.

8

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.

van der Valk M, Gisolf EH, Reiss P, Wit FW, Japour A, Weverling GJ, Danner SA; Prometheus study group. van der Valk M, et al. Among authors: weverling gj. AIDS. 2001 May 4;15(7):847-55. doi: 10.1097/00002030-200105040-00005. AIDS. 2001. PMID: 11399957 Clinical Trial.

9

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.

Veldkamp AI, Weverling GJ, Lange JM, Montaner JS, Reiss P, Cooper DA, Vella S, Hall D, Beijnen JH, Hoetelmans RM. Veldkamp AI, et al. Among authors: weverling gj. AIDS. 2001 Jun 15;15(9):1089-95. doi: 10.1097/00002030-200106150-00003. AIDS. 2001. PMID: 11416710 Clinical Trial.

10

[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].

Jambroes M, Weverling GJ, Reiss P, Danner SA, Jurriaans S, ten Veen JH, van der Ende ME, Schutten M, Schneider MM, Schuurman R, Mulder JW, Kroes AC, Lange JM, de Wolf F; Kliniek en Virologie van het ATHENA-project. Jambroes M, et al. Among authors: weverling gj. Ned Tijdschr Geneeskd. 2001 Aug 18;145(33):1591-7. Ned Tijdschr Geneeskd. 2001. PMID: 11534377 Clinical Trial. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page